Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2020 April;155(2) > Giornale Italiano di Dermatologia e Venereologia 2020 April;155(2):220-2

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Giornale Italiano di Dermatologia e Venereologia 2020 April;155(2):220-2

DOI: 10.23736/S0392-0488.19.06396-X

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Overview on the treatment of Lyme disease in pregnancy

Claudio CONFORTI, Roberta VEZZONI, Chiara RETROSI , Michela LONGONE, Paola CORNELI, Giovanni MAGATON RIZZI, Katiuscia NAN, Nicola DI MEO, Iris ZALAUDEK

Clinic of Dermatology, Maggiore Hospital, University of Trieste, Trieste, Italy



Lyme disease is a tick-borne illness, which is typically caused by Borrelia Burgdoferi. Over time, a typical Borreliosis skin reaction takes shape, i.e. the formation of an annular erythema that tends to expand centrifugally with erythematous edges whose diameter can reach up to 20 cm. The symptoms of Lyme disease are not only cutaneous but there may be a systemic involvement. Obviously, this disease can also affect pregnant women and for this reason this review aims to summarize the main ways of treatment to avoid worsening of the clinical condition in the mother and an eventual, albeit rare, involvement of the fetus.


KEY WORDS: Lyme neuroborreliosis; Skin diseases, infectious; Dermatology

top of page